Medicure (MCUJF) Return on Capital Employed (2009 - 2026)
Medicure (MCUJF) recorded quarterly Return on Capital Employed of 13.71% in Q1 2026, up 645.07% quarter-over-quarter from 2.52% in Q4 2025, and up 3074.0% on a YoY basis from 0.43% in Q1 2025.
Medicure (MCUJF) Return on Capital Employed (2009 - 2026) Analysis & Trends
Medicure's Return on Capital Employed history runs 18 years deep, the most recent figure standing at 13.71% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 3074.0% year-over-year to 13.71%; the TTM figure through Mar 2026 stood at 13.71% (up 3074.0% YoY), while the FY2025 annual figure was 43.94%, down 3089.0% from the prior year.
- Return on Capital Employed was 13.71% for Q1 2026 at Medicure, up from 2.52% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 48.67% in Q1 2023 to a low of 17.03% in Q1 2025.
- Historically, Return on Capital Employed has averaged 5.88% across 5 years, with a median of 0.44% in 2022.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed surged 3542 bps in 2023, then sank 4448 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 36.23% in 2022, then fell by 19 bps to 29.34% in 2023, then tumbled by 145 bps to 13.25% in 2024, then jumped by 81 bps to 2.52% in 2025, then soared by 645 bps to 13.71% in 2026.
- The last three Return on Capital Employed figures came in at 13.71% (Q1 2026), 2.52% (Q4 2025), and 4.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Medicure | - | - | 2.57 Mn | 13.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.71% |
| Dec 31, 2025 | -2.52% |
| Sep 30, 2025 | -4.99% |
| Jun 30, 2025 | -15.73% |
| Mar 31, 2025 | -17.03% |
| Dec 31, 2024 | -13.25% |
| Sep 30, 2024 | -9.01% |
| Jun 30, 2024 | -2.92% |
| Mar 31, 2024 | 4.20% |
| Dec 31, 2023 | 29.34% |
| Mar 31, 2023 | 48.67% |
| Dec 31, 2022 | 36.23% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | 0.44% |
| Mar 31, 2022 | 13.26% |
| Sep 30, 2021 | -19.92% |
| Jun 30, 2021 | -19.83% |
| Mar 31, 2021 | -18.00% |
| Dec 31, 2020 | -27.60% |
| Sep 30, 2020 | -21.81% |